Uroporphyria in mice: Thresholds for hepatic CYP1A2 and iron

Hepatology

Volumn 35, Issue 4, 2002, Pages 912-921

  Gorman, Nadia ^a,b   Ross, Kerry L ^b   Walton, Heidi S ^a,b   Bement, William J ^a   Szakacs, Juliana G ^a   Gerhard, Glenn S ^a,c   Dalton, Timothy P ^c   Nebert, Daniel W ^c   Eisenstein, Richard S ^b   Sinclair, Jacqueline F ^a,b,d   Sinclair, Peter R ^b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; IRON; UROPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IRON INTAKE; IRON METABOLISM; KUPFFER CELL; LIVER LEVEL; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PORPHYRIA; PORPHYRINURIA; PRIORITY JOURNAL;

EID: 18344383322     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.32487     Document Type: Article

References (43)

1. Porphyria cutanea tarda
2. Alcohol intake and porphyria cutanea tarda
3. Porphyria cutanea tarda of the toxic and sporadic varieties
4. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
5. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
6. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: A new model of Fe-mediated porphyria cutanea tarda
7. A mouse model of familial porphyria cutanea tarda
8. Porphyria caused by hexachlorobenzene and other polyhalogenated aromatic hydrocarbons
9. Ascorbic acid deficiency in porphyria cutanea tarda
10. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice
11. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron
12. Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
13. Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice
14. Genetic variation of iron-induced uroporphyria in mice
15. Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice
16. Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism
17. Comparison of the toxicity of TCDD with AHR-genotype and hepatic CYP1A1 isoforms in iron loaded C57BL/6 × DBA/2 F2 mice
18. Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: Potential for modulation of oxidative stress
19. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice
20. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism
21. Toxic potency of 3, 3′, 4, 4′, 5-pentachlorobiphenyl relative to and in combination with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in a subchronic feeding study in the rat
22. Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P450-mediated uroporphyrinogen oxidation
23. Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures
24. Protein measurement with the Folin phenol reagent
25. Chlorinated biphenyls induce cytochrome P4501A2 and uroporphyrin accumulation in cultures of mouse hepatocytes
26. A simple technique for measuring storage iron concentrations in formalinized liver samples
27. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells
28. Iron regulatory proteins and the molecular control of mammalian iron metabolism
29. Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver
30. Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: A study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2)
31. Hemosiderin: Nature, formation, and significance
32. Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: A time-course study
33. Interaction between iron metabolism and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: A hepatic oxidative mechanism
34. Iron deficiency prevents liver toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
35. Uroporphyrinogen oxidation catalyzed by human cytochromes P450
36. Multiple roles of polyhalogenated biphenyls in causing increases in cytochrome P450 and uroporphyrin accumulation in cultured hepatocytes
37. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer
38. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda
39. Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda
40. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
41. Relationship between alcohol and tobacco dependencies among alcoholics who smoke
42. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and haemochromatosis genes accelerates the onset of porphyria cutanea tarda
43. Iron homeostasis: Insights from genetics and animal models